You may also like
PHVT Disruptive Technology Could Revolutionize Heart Failure Treatment
The early clinical promise of percutaneous heart valve technology-a group of minimally invasive devices designed to treat cardiac valve dysfunction without the need for cardiopulmonary bypass-could one day play a prominent role in curbing the costs associated with treating heart failure, which is the current number-one driver of hospitalization among Medicare patients.
7 min read
Dynamic Trends in Cardiac Surgery: Why the Logistic EuroSCORE is no Longer Suitable for Contemporary Cardiac Surgery and Implications for Future Risk Models
The objective of this study was to explore the reasons for the calibration drift of the logistic EuroSCORE.
1 min read
New Requirements for an Individualized Quality Control Plan option for JCAHO Accredited Laboratories (EP Video)
James Halbleib discusses new requirements for IQCP option for clinical laboratories effective Jan. 1, 2016 (22:28 minutes).
1 min read